Learn more about our Global Affairs work.
Akin will provide a CLE program covering the latest legal issues for inbound trade and investment, including the Trump Administration’s approach to trade policy and tariff issues, and strategies medical…
Tariffs on medtech could disrupt supply chains, increase costs, and delay care. Exemptions are needed to protect hospitals, patients, and innovation.
This educational primer will break down tariffs, trade policies, and legal frameworks—giving you the basics you need to navigate upcoming changes.
A breakdown of the administration’s trade policy, highlighting key areas where the U.S. seeks to level the playing field with trading partners through reciprocal tariffs.
A policy memorandum outlining the administration’s strategy for fair and reciprocal trade, addressing tariff imbalances and protecting American industries.
On the Medtech POV podcast, AdvaMed® President and CEO Scott Whitaker sat down with recently retired U.S. Rep. Brad Wenstrup of Ohio, discussing lessons learned from the COVID-19 pandemic, illogical budgetary scoring…
Essential advocacy insights on how new tariffs impact the MedTech industry. Use these key messages when engaging with policymakers, industry stakeholders, and media.
Get clear answers on the scope, impact, and implementation of tariffs on key U.S. trade partners. These FAQs explains tariff rates, exemptions, economic implications, and potential retaliatory actions.
AdvaMed®, the Medtech Association, today released the following statement from President and CEO Scott Whitaker following the imposition of tariffs on products from Canada, Mexico, and China:
A timeline of critical policy and legislative deadlines, including budget resolutions, trade discussions, and key votes that may impact MedTech and global trade policies.